Catalyst Wire Dossier Catalyst Wire Dossier

SPY072

· Spyre Therapeutics, Inc.
Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for SPY072, covering 2026-04-22 to 2026-04-22. Get the full timeline:

Most recent: Clinical Trial Update: A Study of SPY072 in Rheumatic Disease [Phase 2]

See pricing